What Are the Most Common Side Effects of GLP-1 Medications?
Written by YiQiu Hu, NMD
Arizona-licensed naturopathic physician and virtual concierge medicine provider
Published August 2026 | Medically reviewed August 2026
GLP-1 medications such as semaglutide and tirzepatide have become important treatment options for many patients with overweight or obesity. Although these medications can be very effective, they can also cause side effects—particularly while treatment is being started or the dose is being increased.
The most common GLP-1 side effects involve the digestive system. Nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, and reflux are among the symptoms reported most frequently with commonly used GLP-1-based weight-loss medications.
Fortunately, many gastrointestinal side effects are manageable and may become less noticeable as the body adjusts to treatment. However, persistent or severe symptoms should not simply be ignored.
Understanding what is expected—and what may indicate a more serious problem—can make GLP-1 treatment considerably safer and more comfortable.
If you are unfamiliar with this class of medications, start with my guide to how GLP-1 medications work for weight loss.
What Are the Most Common GLP-1 Side Effects?
The most frequently reported side effects are gastrointestinal.
Depending on the medication and dose, patients may experience:
Nausea
Diarrhea
Constipation
Vomiting
Abdominal discomfort or pain
Indigestion
Heartburn or reflux
Bloating
Gas
Belching
Reduced appetite
Other possible effects can include fatigue, headache, dizziness, injection-site reactions, and hair loss with certain medications.
Not every patient develops these symptoms, and two people taking the same medication can have very different experiences.
One patient may notice almost no gastrointestinal effects, while another may have enough nausea or constipation that the dose or treatment plan needs to be adjusted.
How Common Is Nausea With GLP-1 Medications?
Nausea is one of the most frequently reported GLP-1 side effects.
For example, in adult weight-management trials included in current FDA prescribing information, nausea was reported by approximately 44% of participants receiving Wegovy (semaglutide) compared with 16% receiving placebo.
In clinical trials of Zepbound (tirzepatide), nausea occurred in approximately 25% to 29% of participants, depending on dose, compared with 8% receiving placebo.
These percentages should not be interpreted as a direct comparison between the medications because they come from different clinical trials.
More importantly, experiencing some nausea does not necessarily mean the medication needs to be discontinued.
The severity, duration, ability to maintain hydration and nutrition, and relationship to medication dosing all matter.
Why Do GLP-1 Medications Cause Digestive Side Effects?
GLP-1 medications influence several systems involved in digestion and appetite.
One of their effects is slowing gastric emptying, meaning food can remain in the stomach longer before moving into the small intestine. They also affect signaling between the gastrointestinal tract and areas of the brain involved in appetite and fullness.
These effects can help patients feel satisfied after smaller amounts of food, but they can also contribute to nausea, fullness, bloating, reflux, or abdominal discomfort.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide activates both GIP and GLP-1 receptors, although it is commonly grouped with GLP-1 medications when discussing modern medical weight management.
You can learn more about these mechanisms in GLP-1 Medications Explained: How They Work for Weight Loss.
When Are GLP-1 Side Effects Usually the Worst?
Side effects are often most noticeable when treatment is first started or following a dose increase.
This is one reason medications such as semaglutide and tirzepatide are generally started at relatively low doses and increased gradually rather than beginning immediately at the full maintenance dose.
Current Wegovy prescribing information specifically recommends following its dose-escalation schedule to reduce gastrointestinal adverse reactions and allows escalation to be delayed when a dose is not tolerated.
The Zepbound clinical-trial data similarly show that most nausea, vomiting, and diarrhea occurred during dose escalation and tended to decrease over time.
This is an important principle in medical weight loss:
The goal is not to reach the highest dose as quickly as possible.
The appropriate dose is one that provides meaningful benefit while remaining reasonably tolerable.
Patients should not increase or decrease their medication dose on their own without discussing the change with their prescribing healthcare professional.
Is Constipation Common With GLP-1 Medications?
Yes.
Constipation is another commonly reported side effect, and it can sometimes become more troublesome than nausea.
In adult Wegovy weight-management trials, constipation occurred in approximately 24% of participants receiving semaglutide compared with 11% receiving placebo.
With Zepbound, constipation occurred in approximately 11% to 17% of participants depending on the dose, compared with 5% receiving placebo.
Reduced overall food intake, changes in meal composition, inadequate fluid intake, reduced fiber intake, and medication-related changes in gastrointestinal motility can all potentially contribute.
This is one reason nutrition and hydration should remain part of a physician-guided medical weight loss plan rather than focusing exclusively on medication.
For more information about maintaining good nutrition during weight management, visit the Healthy Living & Nutrition Resource Center.
What About Diarrhea and Vomiting?
Both can occur.
Diarrhea was reported in approximately 30% of adults receiving Wegovy in the weight-management trials described in the FDA label, while vomiting occurred in approximately 24%.
For Zepbound, diarrhea occurred in approximately 19% to 23% of participants and vomiting in approximately 8% to 13%, depending on dose.
Occasional mild symptoms may be manageable.
Persistent vomiting or diarrhea deserves more attention because it can lead to dehydration.
Both the semaglutide and tirzepatide prescribing information warn about acute kidney injury related to volume depletion, particularly when gastrointestinal symptoms result in significant dehydration.
Patients experiencing persistent vomiting or diarrhea, difficulty keeping fluids down, or symptoms suggesting significant dehydration should contact their healthcare professional.
Can GLP-1 Medications Cause Heartburn or Indigestion?
Yes.
Because these medications affect stomach emptying and gastrointestinal function, some patients notice:
Heartburn
Acid reflux
Indigestion
Bloating
Excessive fullness
Belching
Gas
These are recognized adverse reactions in current semaglutide and tirzepatide prescribing information.
Symptoms can sometimes be influenced by the medication dose and the amount of food eaten at one time.
Persistent reflux, significant abdominal discomfort, or difficulty eating adequately should be discussed with the prescribing physician rather than automatically accepting the symptoms as part of treatment.
Is Fatigue a GLP-1 Side Effect?
Fatigue can occur with both semaglutide and tirzepatide.
Sometimes the medication itself may contribute.
In other situations, fatigue during weight loss may also be related to substantially reduced calorie intake, inadequate protein or fluid intake, sleep disruption, another medication, or an unrelated medical condition.
For that reason, persistent fatigue should not automatically be attributed to the GLP-1 medication.
A good medical weight loss program looks at the patient's overall health rather than treating every symptom as an inevitable consequence of the medication.
Can GLP-1 Medications Cause Hair Loss?
Hair loss has been reported during treatment with both semaglutide and tirzepatide.
In the adult Wegovy trials summarized in current FDA labeling, hair loss was reported in approximately 3% of treated participants. It was reported in approximately 4% to 5% of participants receiving Zepbound in the weight-management trials.
Hair shedding during significant weight loss can have multiple possible causes and does not necessarily mean that the medication is directly damaging hair follicles.
Rapid weight loss, major changes in calorie intake, inadequate protein or nutrient intake, thyroid disease, iron deficiency, stress, and other medical factors may also need to be considered.
Persistent or significant hair loss deserves an individualized evaluation.
Are GLP-1 Side Effects a Sign That the Medication Is Working?
Not necessarily.
More side effects do not automatically mean more weight loss.
A patient does not need to feel nauseated in order for a GLP-1 medication to work.
In fact, excessive appetite suppression or gastrointestinal symptoms can become counterproductive if they prevent someone from consuming adequate fluids, protein, calories, vitamins, and minerals.
The objective of treatment should be effective appetite regulation and sustainable weight loss—not making the patient feel as sick as possible.
A higher dose is therefore not automatically a better dose.
How Can GLP-1 Side Effects Be Managed?
Management depends on the medication, the symptom, its severity, and the patient's individual medical history.
Some of the most important considerations include adequate hydration, following the prescribed dose-escalation schedule, avoiding unsupervised dose increases, and discussing persistent symptoms with the prescribing healthcare professional.
If symptoms become significant after a dose increase, the prescriber may need to consider whether the dose-escalation schedule, current dose, other medications, eating patterns, or treatment itself should be reassessed.
GLP-1 therapy should be treated as medical care rather than simply obtaining a prescription and increasing the dose every few weeks regardless of how the patient feels.
At Ask Dr. Hu, physician-supervised medical weight loss includes individualized evaluation, medication management when appropriate, lifestyle and nutrition guidance, and ongoing monitoring.
When Should I Contact My Physician About GLP-1 Side Effects?
Contact your healthcare professional if side effects are persistent, worsening, interfering with normal eating or drinking, or causing concern.
Examples include:
Repeated or persistent vomiting
Persistent diarrhea
Significant constipation that is not improving
Inability to maintain adequate hydration
Severe or persistent abdominal pain
Significant abdominal swelling or gastrointestinal symptoms
Symptoms of low blood sugar, particularly if you also use insulin or certain diabetes medications
Significant allergic symptoms
New or concerning symptoms after a medication dose change
Both current semaglutide and tirzepatide labeling warn that gastrointestinal adverse reactions can occasionally become severe.
What Serious GLP-1 Side Effects Should Patients Know About?
Serious complications are considerably less common than nausea, constipation, diarrhea, or other routine gastrointestinal symptoms, but they are important to recognize.
Potential serious risks described in FDA prescribing information include:
Acute pancreatitis
Gallbladder disease
Severe gastrointestinal reactions
Kidney injury associated with dehydration
Serious hypersensitivity or allergic reactions
Hypoglycemia, particularly when combined with insulin or certain diabetes medications
Diabetic retinopathy complications in certain patients with diabetes
Persistent severe abdominal pain, particularly pain that may radiate toward the back and may occur with or without vomiting, can be a warning symptom of pancreatitis and requires prompt medical evaluation.
Patients with severe symptoms should not wait for a routine follow-up appointment.
What About the Thyroid Cancer Warning?
Semaglutide and tirzepatide carry FDA boxed warnings regarding thyroid C-cell tumors.
These medications caused thyroid C-cell tumors in animal studies. Whether they cause medullary thyroid carcinoma in humans has not been established.
They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
This is one of several reasons a complete medical history should be reviewed before beginning treatment.
If you are unsure whether medication may be appropriate for you, read Am I a Candidate for a Medical Weight Loss Program?.
Are GLP-1 Medications Safe Despite These Side Effects?
For appropriately selected patients, GLP-1-based medications can be effective tools for long-term weight management.
But "safe" does not mean "free of side effects."
The appropriate question is whether the expected benefits outweigh the potential risks for a particular patient—and whether treatment is being monitored appropriately.
Medical history, current medications, gastrointestinal health, gallbladder and pancreatic history, diabetes medications, kidney function, pregnancy considerations, thyroid history, and other individual factors may all influence that decision.
The experience of taking a GLP-1 medication should therefore be individualized rather than following the same dosing strategy for everyone.
Frequently Asked Questions
Do GLP-1 side effects eventually go away?
Some gastrointestinal side effects become less noticeable as the body adjusts to treatment. Zepbound clinical-trial data, for example, show that most nausea, vomiting, and diarrhea occurred during dose escalation and decreased over time. However, persistent symptoms should be discussed with your prescriber rather than simply waiting indefinitely for them to disappear.
Is nausea normal when starting a GLP-1 medication?
Mild nausea is common, particularly during treatment initiation or dose escalation. Severe nausea, repeated vomiting, inability to stay hydrated, or symptoms that are not improving deserve medical attention.
Which GLP-1 medication has the fewest side effects?
There is no single medication that is best tolerated by everyone. Different medications were also studied in different clinical trials, so percentages from separate studies should not be interpreted as simple head-to-head comparisons. Individual response and tolerability can vary substantially.
Should I stop my medication if I have side effects?
Do not make medication changes solely based on general information online. Mild symptoms may not require stopping treatment, while certain severe symptoms can require prompt discontinuation and medical evaluation. Contact the healthcare professional prescribing the medication for individualized instructions.
Does a higher GLP-1 dose cause more weight loss?
Higher doses can provide additional benefit for some patients, but the best dose is not necessarily the highest available dose. Treatment response and tolerability both matter, and FDA-approved dosing schedules use gradual dose escalation in part to improve gastrointestinal tolerance.
The Bottom Line
The most common side effects of GLP-1 medications are nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, bloating, and reflux.
For many patients, these symptoms are mild to moderate and can become easier to tolerate over time, particularly when medication is increased gradually.
However, persistent nausea, repeated vomiting, significant constipation, severe abdominal pain, dehydration, or other concerning symptoms should not simply be accepted as the price of losing weight.
Good medical weight loss treatment balances effectiveness with tolerability.
The objective is not to reach the highest medication dose or lose weight as quickly as possible. It is to find a treatment strategy that improves health while allowing the patient to maintain adequate nutrition, hydration, muscle mass, physical function, and quality of life.
Explore the Medical Weight Loss Resource Center for additional physician-written information about GLP-1 medications, nutrition, weight loss, and long-term weight management.
If you are considering GLP-1 treatment, you can also learn more about Ask Dr. Hu's physician-supervised Medical Weight Loss program.
Medical Accuracy and Evidence Standards
This article was written and medically reviewed by YiQiu Hu, NMD, an Arizona-licensed naturopathic physician and founder of Ask Dr. Hu.
The medication safety information on this page was reviewed against current FDA prescribing information available in August 2026. Medication labeling and safety recommendations can change as additional evidence becomes available.
Key references include:
U.S. Food and Drug Administration — Wegovy (semaglutide) Prescribing Information
U.S. Food and Drug Administration — Zepbound (tirzepatide) Prescribing Information
This information is provided for general educational purposes and does not replace individualized medical advice. Medication decisions should be made with a qualified healthcare professional who can consider your medical history, medications, symptoms, and individual risk factors.
About the Author
YiQiu Hu, NMD is an Arizona-licensed naturopathic physician and founder of Ask Dr. Hu. His clinical approach emphasizes personalized, evidence-informed care with a focus on prevention, metabolic health, medical weight management, and helping patients understand the reasoning behind their treatment options.
Through Ask Dr. Hu, he provides concierge medical care and physician-supervised medical weight loss services for patients throughout Arizona.